Phenobarbital pharmacokinetics and bioavailability in adults

Journal of Clinical Pharmacology
E NelsonD Perrier

Abstract

The pharmacokinetics and bioavailability of phenobarbital were examined in six healthy adult subjects after a 2.6 mg/kg intravenous and a 2.9 mg/kg oral dose. Serum concentrations of phenobarbital were followed by means of a high pressure liquid chromatographic assay for 21 days after drug administration. After the intravenous dose, the mean distribution half-life was 0.18 hour and the mean elimination half-life was 5.8 days. Mean total body clearance and mean renal clearance were 3.0 ml/hr/kg and 0.8 ml/hr/kg, respectively. The apparent volume of distribution was 0.60 liter/kg. After administration of phenobarbital tablets, the maximum phenobarbital serum concentration was 5.5 mg/liter at 2.3 hours after the dose. Adjusted absolute availability of phenobarbital from the tablets studied was 94.9 per cent (range 81-111.9 per cent). The elimination half-life averaged 5.1 days for the oral dose. There was no evidence of autoinduction of phenobarbital elimination over the study period.

References

Feb 1, 1978·Journal of Clinical Pharmacology·C T ViswanathanP G Welling
Mar 1, 1978·Acta paediatrica Scandinavica·L O BoréusN Kallberg
Mar 1, 1978·Clinical Pharmacology and Therapeutics·W PitlickC E Pippenger
Dec 19, 1975·European Journal of Clinical Pharmacology·N KallbergL O Boréus
Apr 1, 1974·Journal of Pharmacokinetics and Biopharmaceutics·H G BoxenbaumR M Elashoff
Dec 1, 1968·Archives of Neurology·F BUCHTHALH Simonsen
Jan 1, 1980·European Journal of Clinical Pharmacology·P J Neuvonen, E Elonen
Aug 1, 1957·The Journal of Clinical Investigation·W J WADDELL, T C BUTLER
Dec 1, 1963·Epilepsia·O SVENSMARK, F BUCHTHAL

Citations

Sep 9, 1982·The New England Journal of Medicine·M J BergG F Johnson
Aug 1, 1993·Journal of Clinical Pharmacy and Therapeutics·A C Alonso GonzalezA Dominguez-Gil Hurle
Mar 15, 2013·American Journal of Physiology. Cell Physiology·Ajit DashBrian R Wamhoff
May 29, 2012·Expert Opinion on Drug Metabolism & Toxicology·Ajit DashBrian R Wamhoff
Feb 14, 2016·Critical Care Nursing Clinics of North America·Jennifer D Robinson
Nov 9, 2011·Advanced Drug Delivery Reviews·Cecilie Johannessen LandmarkTorbjörn Tomson
May 5, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Graham LappinColin Garner
Jun 15, 2015·Epilepsy & Behavior : E&B·Ilo E Leppik, Sima I Patel
Aug 7, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Marc LindenbergJennifer B Dressman
Apr 22, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Daniela MilosheskaTomaž Vovk
May 17, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Swantje VöllerDINO study group
Apr 22, 2011·Journal of Pharmacy Practice·Nida Siddiqi, Kwaku Marfo
Jun 14, 2018·Epilepsia·Brady S MoffettSimon Y Kayyal
Sep 1, 1986·Biopharmaceutics & Drug Disposition·L J AdlerP R Gwilt
Jun 30, 2018·Therapeutic Drug Monitoring·P N PatsalosDave J Berry
Dec 6, 2018·Journal of Intensive Care Medicine·Nidhi RavishankarFawaz Al-Mufti
Nov 9, 2014·European Journal of Clinical Pharmacology·Katarina VučićevićMilica Prostran
May 17, 2019·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Masumeh GhazanfarpourRamin Rezaee
Jan 5, 2013·Therapeutic Drug Monitoring·P N Patsalos, Dave J Berry
Aug 30, 2020·British Journal of Clinical Pharmacology·Ruud H J VerstegenShinya Ito
Jul 22, 2018·European Journal of Drug Metabolism and Pharmacokinetics·Hirokazu NakayamaToshiaki Kato
Sep 1, 1990·The Journal of International Medical Research·L Pérez-GallardoJ F Escanero
Mar 1, 2002·Biopharmaceutics & Drug Disposition·A MirfazaelianM Mahmoudian
Oct 14, 2020·Expert Opinion on Drug Metabolism & Toxicology·Matthijs W van HoogdalemTomoyuki Mizuno
Dec 11, 2020·Expert Review of Neurotherapeutics·Giovanni MastroianniEdoardo Ferlazzo

Related Concepts

Biological Availability
Half-Life
Luminal

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

The Tendon Seed Network

Tendons are rich in the extracellular matrix and are abundant throughout the body providing essential roles including structure and mobility. The transcriptome of tendons is being compiled to understand the micro-anatomical functioning of tendons. Discover the latest research pertaining to the Tendon Seed Network here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Incretins

Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Long COVID-19

“Long Covid-19” describes illness in patients who are reporting long-lasting effects of the SARS-CoV-19 infection, often long after they have recovered from acute Covid-19. Ongoing health issues often reported include low exercise tolerance and breathing difficulties, chronic tiredness, and mental health problems such as post-traumatic stress disorder and depression. This feed follows the latest research into Long Covid.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.